+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aminoglycosides Market by Product Type, Route Administration, Application, Distribution Channel, Formulation - Global Forecast to 2030- Product Image
Aminoglycosides Market by Product Type, Route Administration, Application, Distribution Channel, Formulation - Global Forecast to 2030- Product Image
Sale

Aminoglycosides Market by Product Type, Route Administration, Application, Distribution Channel, Formulation - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977762
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The aminoglycoside antibiotics market is experiencing dynamic shifts, driven by evolving clinical needs, regulatory changes, and technological advancements. Senior executives need precise market intelligence and actionable segmentation analysis to remain well-positioned in this specialized pharmaceutical landscape.

Market Snapshot: Aminoglycosides Market at a Glance

The Aminoglycosides Market grew from USD 2.02 billion in 2024 to USD 2.12 billion in 2025. It is expected to continue growing at a CAGR of 4.79%, reaching USD 2.67 billion by 2030. High demand persists across hospitals, outpatient centers, and specialty clinics, with product and route diversification reinforcing robust market momentum for aminoglycoside antibiotics.

Scope & Segmentation

This report delivers a multi-faceted view into the aminoglycoside antibiotics market, including analysis broken down by product, application, route, channel, and region. Senior stakeholders can leverage detailed insights to refine commercialization and procurement strategies, or to identify new partnership opportunities.

  • Product Types: Amikacin, Gentamicin, Neomycin, Streptomycin, Tobramycin
  • Routes of Administration: Injectable (intramuscular, intravenous), Oral (capsules, tablets), Topical (ear drops, eye drops, skin creams)
  • Applications: Ambulatory surgical centers, Clinics, Hospitals
  • Distribution Channels: Hospital pharmacy, Online pharmacy (marketplaces, pharmacy websites), Retail pharmacy, Wholesale distributors
  • Formulations: Ointment, Powder, Solution
  • Regional Coverage: Americas (United States [California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio], Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Baxter International Inc., Amneal Pharmaceuticals Inc., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Cipla Limited

Key Takeaways for Senior Decision-Makers

  • Innovation in molecular optimization and drug delivery is enhancing therapeutic outcomes and supporting market differentiation.
  • Strategic collaborations between pharmaceutical manufacturers and biotechnology firms foster pipeline diversification and facilitate the launch of next-generation antibiotics.
  • Lifecycle management and expanding indications for legacy products are extending the commercial viability of established aminoglycoside compounds.
  • Regional dynamics demand tailored market entry strategies, with developed markets emphasizing advanced formulations and emerging regions prioritizing access and cost-efficiency.
  • Shifts toward real-time pharmacovigilance, predictive analytics, and digital health platforms are augmenting post-market surveillance and supply chain transparency.

Tariff Impact: Navigating Cost and Supply Chain Adjustments

The 2025 introduction of United States tariffs has altered cost structures in aminoglycoside production and importation. Increased duties have prompted manufacturers to revisit supply sources and strengthen local production capacities. Competitive responses include accelerated domestic facility development and selective absorption of cost increases to maintain critical hospital contracts. Procurement and distributor negotiations now require dynamic contract management to manage price volatility while maintaining supply reliability for essential antibiotics.

Methodology & Data Sources

This analysis is built on a multi-method approach, integrating primary interviews with key opinion leaders, supply chain managers, and hospital pharmacists, alongside secondary research of peer-reviewed content, regulatory filings, and public financial disclosures. Cross-verification across approval records, expenditure datasets, and official trade communications ensures accurate, objective, and reliable insights throughout the research process.

Aminoglycoside Antibiotics Market: Why This Report Matters

  • Unlocks actionable intelligence for portfolio expansion, region-specific strategy, and competitive positioning within the aminoglycoside antibiotics market.
  • Enables robust risk assessment and procurement planning in light of legislative changes and evolving supply dynamics.
  • Supports leadership in investment prioritization, research focus, and partnership alignment for sustained market impact.

Conclusion

This report empowers decision-makers to navigate the complex intersection of regulation, innovation, and trade in the aminoglycoside antibiotics sector. By leveraging nuanced insights and rigorous analysis, stakeholders can drive more effective strategies for accelerated growth and operational resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Aminoglycosides Market, by Product Type
8.1. Introduction
8.2. Amikacin
8.3. Gentamicin
8.4. Neomycin
8.5. Streptomycin
8.6. Tobramycin
9. Aminoglycosides Market, by Route Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Oral
9.3.1. Capsules
9.3.2. Tablets
9.4. Topical
9.4.1. Ear Drops
9.4.2. Eye Drops
9.4.3. Skin Creams
10. Aminoglycosides Market, by Application
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospital
11. Aminoglycosides Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Marketplaces
11.3.2. Pharmacy Websites
11.4. Retail Pharmacy
11.5. Wholesale Distributors
12. Aminoglycosides Market, by Formulation
12.1. Introduction
12.2. Ointment
12.3. Powder
12.4. Solution
13. Americas Aminoglycosides Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Aminoglycosides Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Aminoglycosides Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc.
16.3.4. Fresenius Kabi AG
16.3.5. Hikma Pharmaceuticals PLC
16.3.6. Baxter International Inc.
16.3.7. Amneal Pharmaceuticals Inc.
16.3.8. Pfizer Inc.
16.3.9. Dr. Reddy's Laboratories Ltd.
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AMINOGLYCOSIDES MARKET MULTI-CURRENCY
FIGURE 2. AMINOGLYCOSIDES MARKET MULTI-LANGUAGE
FIGURE 3. AMINOGLYCOSIDES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMINOGLYCOSIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AMINOGLYCOSIDES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AMINOGLYCOSIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AMINOGLYCOSIDES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY STREPTOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOBRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EAR DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SKIN CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY PHARMACY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES AMINOGLYCOSIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 65. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 66. CANADA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 67. CANADA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. CANADA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 70. CANADA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 75. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 76. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 122. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 130. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 131. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 134. FRANCE AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 144. ITALY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. ITALY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 147. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 148. ITALY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 149. ITALY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. ITALY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. ITALY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 152. ITALY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 153. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 156. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 157. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 158. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 161. SPAIN AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 189. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 192. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 193. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 194. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 197. DENMARK AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. QATAR AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. QATAR AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 210. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 211. QATAR AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 212. QATAR AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. QATAR AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. QATAR AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 215. QATAR AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 216. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 220. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 221. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 224. FINLAND AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 243. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 247. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 248. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 251. EGYPT AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 252. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 255. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 256. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 257. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 260. TURKEY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 270. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 274. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 275. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 278. NORWAY AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. POLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. POLAND AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 282. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 283. POLAND AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 284. POLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. POLAND AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. POLAND AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 287. POLAND AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 307. CHINA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. CHINA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 310. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 311. CHINA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 312. CHINA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. CHINA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. CHINA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 315. CHINA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 316. INDIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 318. INDIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 319. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 320. INDIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 321. INDIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. INDIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. INDIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 324. INDIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 325. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 328. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 329. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 330. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 333. JAPAN AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 340. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 342. AUSTRALIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 347. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 348. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 351. SOUTH KOREA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA AMINOGLYCOSIDES MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 361. THAILAND AMINOGLYCOSIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Aminoglycosides market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals PLC
  • Baxter International Inc.
  • Amneal Pharmaceuticals Inc.
  • Pfizer Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.67 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030 - Product Image

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030

  • Report
  • 105 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Image

Aminoglycosides Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Aminoglycosides - Global Strategic Business Report - Product Image

Aminoglycosides - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Aminoglycosides Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Aminoglycosides Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Antibacterial Drugs Market by Drug Class, Route of Administration, Spectrum of Activity, Mechanism of Action, Indication, Point of Sale, Distribution Channel - Global Forecast to 2030 - Product Image

Antibacterial Drugs Market by Drug Class, Route of Administration, Spectrum of Activity, Mechanism of Action, Indication, Point of Sale, Distribution Channel - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.